TRA2B and osteosarcoma: More recently, Zhang et al. demonstrated that by targeting TRA2B, exosome derived miR-206 derived from BMSC could be transferred into osteosarcoma cells and suppress osteosarcoma progression (Zhang et al., 2020a).